(Q33491075)
Statements
Phase I and pharmacokinetic studies of topotecan administered as a 72 or 120 h continuous infusion (English)
H A Burris
A Awada
J G Kuhn
J R Eckardt
P W Cobb
D A Rinaldi
S Fields
L Smith
scientific article